Skip to main content

Test Price

2,800 AED

✅ Home Collection Available

DNAH11 Gene Primary Ciliary Dyskinesia Type 7 Genetic Test in UAE | AED 2800 | 2026 DHA Guidelines

تحليل جين DNAH11 للكشف عن خلل الحركة الهدبية الأولي من النوع 7 في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي

Executive Summary | ملخص تنفيذي

  • Accuracy Guarantee: ضمان الدقة: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
  • Premium Logistics: خدمات لوجستية متميزة: Paid Hospital‑Grade Home Collection with ISO‑Certified Cold‑Chain Transport and VIP Mobile Phlebotomy (8 AM – 11 PM).
  • Clinical Guidance: إرشادات طبية: Telephonic Post‑Test Clinical Guidance for result interpretation by a certified genetic counsellor.
  • Insurance: التأمين: Direct Billing Verification via WhatsApp at +971 54 548 8731.

Clinical Overview

The DNAH11 gene NGS test detects pathogenic variants associated with Primary Ciliary Dyskinesia type 7, a hereditary disorder that impairs mucociliary clearance and causes chronic ear, nose, throat, and lung infections. This UAE‑based next‑generation sequencing assay provides comprehensive coverage of all coding exons and splice junctions, delivering a definitive genetic diagnosis to guide personalised management – available with a convenient home collection service.

Feature Our Test (DNAH11 NGS) Closest Alternative (Targeted Panel)
Precision Full gene sequencing – detects SNVs, indels, and CNVs across all coding regions Limited to pre‑selected common mutations; misses rare or novel variants
Methodology Illumina Next‑Generation Sequencing (NGS) with orthogonal confirmation Sanger sequencing of a few exons
Turnaround Time 3 – 4 Weeks 5 – 6 Weeks

Physician Insight & Safety Protocol

“As an ENT consultant with deep expertise in hereditary respiratory disorders, I urge that genetic test results always be correlated with clinical symptoms and ciliary ultrastructure studies. This DNAH11 analysis offers families a precise molecular diagnosis, paving the way for early intervention and prevention of irreversible lung damage. Please consult your specialist before making any therapeutic changes.”

— Dr. PRABHAKAR REDDY, DHA License 61713011

⚠ MEDICATION ADVISORY

Do not discontinue any prescribed medication, including bronchodilators or antibiotics, without first consulting your treating physician. Genetic findings must be integrated into a broader care plan.

🚨 Patient Safety & Exclusion Criteria

  • Absolute Exclusion: Severe coagulopathy (INR > 3.0), acute febrile illness with systemic instability, or inability to provide informed consent.
  • Relative Exclusion (consult our hotline): Recent major surgery, active chemotherapy, or severe anaemia (Hb < 8 g/dL).
  • Emergency Red Flags: If you experience acute respiratory distress, chest pain, high fever (>38.5 °C), or sudden hearing loss, seek emergency medical attention immediately – do not wait for a genetic test.
  • Minors: Testing on individuals below 18 years is performed strictly in accordance with UAE CDS Law 2026 and requires legal guardian consent.

UAE Regulatory Compliance: Federal Decree‑Law No. 41 of 2024 (Art. 87) on Health Data, UAE Personal Data Protection Law (PDPL), and UAE CDS Law 2026. All genetic data is processed within the UAE under ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) certified protocols. Home collection adheres to MOHAP/DHA clinical standards.

Frequently Asked Questions

1. What exactly does the DNAH11 gene test diagnose?

This test identifies pathogenic mutations in the DNAH11 gene responsible for Primary Ciliary Dyskinesia type 7, a hereditary condition that disrupts cilia function and leads to lifelong ear, sinus, and lung infections. يحدد هذا التحليل الطفرات الممرضة في جين DNAH11 المسببة لخلل الحركة الهدبية الأولي من النوع 7، وهو اضطراب وراثي يعطل وظيفة الأهداب ويؤدي إلى التهابات مزمنة في الأذن والجيوب الأنفية والرئتين.

2. How is the sample collected and what is the turnaround time?

A licensed phlebotomist collects a small blood sample (or a drop of blood on an FTA card) during a paid home visit between 8 AM and 11 PM, and results are delivered in 3‑4 weeks after cold‑chain transport to our UAE reference laboratory. يقوم فني مختبر مرخص بجمع عينة دم صغيرة (أو قطرة دم على بطاقة FTA) خلال زيارة منزلية مدفوعة بين الساعة 8 صباحًا و11 مساءً، وتصدر النتائج خلال 3 إلى 4 أسابيع بعد النقل المبرد إلى مختبرنا المرجعي في الإمارات.

3. Is this genetic covered by UAE health insurance?

Many UAE medical insurance plans cover medically indicated genetic testing; our dedicated insurance team will promptly verify your policy and process direct billing upon receiving your Emirates ID via WhatsApp at +971 54 548 8731. تغطي العديد من خطط التأمين الصحي في الإمارات الفحوصات الجينية الطبية الضرورية؛ وسيتحقق فريق التأمين المختص لدينا فورًا من وثيقتك ويقوم بإجراء الفوترة المباشرة فور استلام هويتك الإماراتية عبر واتساب على الرقم التالي: +971 54 548 8731.

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians